Sara Frank Moderating Gene Therapy Discussion at Specialty Products Compliance Congress

Sara Frank is moderating the fireside chat, “The Rise of Cell and Gene Therapy and How to Remain Compliant Amid Industry Shifts” at the Compliance Congress for Specialty Products on Wednesday, September 20th from 1:30 - 2:15 p.m.

The discussion will focus on the transformative and undeniable potential of cell and gene therapy, as well as the unique regulatory challenges that arise as the science continues to develop. The conversation will also take a closer look into the emerging trends, challenges and requirements associated with this new era of cell and gene therapy, and in turn the compliance and legal risks that may surface.

More information can be found here.